133 related articles for article (PubMed ID: 37955056)
1. Pain in patients with motor neuron disease: Variation of pain and association with disease severity, health-related quality of life and depression - A longitudinal study.
Spörndly-Nees S; Jakobsson Larsson B; Zetterberg L; Åkerblom Y; Nyholm D; Åsenlöf P
Palliat Support Care; 2023 Nov; ():1-8. PubMed ID: 37955056
[TBL] [Abstract][Full Text] [Related]
2. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
[TBL] [Abstract][Full Text] [Related]
3. Pain, disease severity and associations with individual quality of life in patients with motor neuron diseases.
Åkerblom Y; Zetterberg L; Larsson BJ; Nyholm D; Nygren I; Åsenlöf P
BMC Palliat Care; 2021 Oct; 20(1):154. PubMed ID: 34641829
[TBL] [Abstract][Full Text] [Related]
4. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
5. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
James E; Ellis C; Brassington R; Sathasivam S; Young CA
Cochrane Database Syst Rev; 2022 May; 5(5):CD006981. PubMed ID: 35593746
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
[TBL] [Abstract][Full Text] [Related]
7. Cognitive deficits have only limited influence on health-related quality of life in amyotrophic lateral sclerosis.
Prell T; Witte OW; Gunkel A; Grosskreutz J
Aging Ment Health; 2020 Dec; 24(12):1963-1967. PubMed ID: 31317778
[TBL] [Abstract][Full Text] [Related]
8. Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease.
Cui F; Zhu W; Zhou Z; Ren Y; Li Y; Li M; Huo Y; Huang X
Neuropsychiatr Dis Treat; 2015; 11():2847-54. PubMed ID: 26604769
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire.
Shamshiri H; Eshraghian MR; Ameli N; Nafissi S
Iran J Neurol; 2013; 12(3):102-5. PubMed ID: 24250914
[TBL] [Abstract][Full Text] [Related]
10. A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in Germany.
Peseschkian T; Cordts I; Günther R; Stolte B; Zeller D; Schröter C; Weyen U; Regensburger M; Wolf J; Schneider I; Hermann A; Metelmann M; Kohl Z; Linker RA; Koch JC; Büchner B; Weiland U; Schönfelder E; Heinrich F; Osmanovic A; Klopstock T; Dorst J; Ludolph AC; Boentert M; Hagenacker T; Deschauer M; Lingor P; Petri S; Schreiber-Katz O
Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33799476
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.
Ng L; Khan F; Young CA; Galea M
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011776. PubMed ID: 28072907
[TBL] [Abstract][Full Text] [Related]
12. Pain-Related Factors and Their Impact on Quality of Life in Chinese Patients With Amyotrophic Lateral Sclerosis.
An R; Wu Y; Li Y; Li X; Ai S; Xu Y; He C
Front Neurosci; 2022; 16():897598. PubMed ID: 35924224
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis.
Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD
Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151
[TBL] [Abstract][Full Text] [Related]
14. Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS).
Paganoni S; McDonnell E; Schoenfeld D; Yu H; Deng J; Atassi H; Sherman A; Yerramilli-Rao P; Cudkowicz M; Atassi N
J Neurol Neurophysiol; 2017 Apr; 8(2):. PubMed ID: 28798889
[TBL] [Abstract][Full Text] [Related]
15. Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis.
Prell T; Steinbach R; Witte OW; Grosskreutz J
eNeurologicalSci; 2019 Sep; 16():100198. PubMed ID: 31384673
[TBL] [Abstract][Full Text] [Related]
16. Variation in assistive technology use in Motor Neuron Disease according to clinical phenotypes and ALS Functional Rating Scale - Revised Score: A prospective observational study.
Connors K; Mahony L; Morgan P
NeuroRehabilitation; 2019; 44(2):303-313. PubMed ID: 31006691
[TBL] [Abstract][Full Text] [Related]
17. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options.
Trail M; Nelson ND; Van JN; Appel SH; Lai EC
J Neurol Sci; 2003 May; 209(1-2):79-85. PubMed ID: 12686407
[TBL] [Abstract][Full Text] [Related]
18. Associations between illness cognitions and health-related quality of life in the first year after diagnosis of amyotrophic lateral sclerosis.
Kruitwagen-van Reenen ETH; Post MWM; van Groenestijn A; van den Berg LH; Visser-Meily JMA
J Psychosom Res; 2020 May; 132():109974. PubMed ID: 32155469
[TBL] [Abstract][Full Text] [Related]
19. Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocol.
Beswick E; Glasmacher SA; Dakin R; Newton J; Carson A; Abrahams S; Chandran S; Pal S
BMJ Open; 2021 Mar; 11(3):e044996. PubMed ID: 33757953
[TBL] [Abstract][Full Text] [Related]
20. Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data.
Prell T; Gaur N; Steinbach R; Witte OW; Grosskreutz J
Health Qual Life Outcomes; 2020 May; 18(1):117. PubMed ID: 32357946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
